Related references
Note: Only part of the references are listed.Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia
Agnes Linglart et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Incidence of Complications in 25 Adult Patients With X-linked Hypophosphatemia
Hajime Kato et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Incidence of Complications in 25 Adult Patients With X-linked Hypophosphatemia
Hajime Kato et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Enthesopathy, Osteoarthritis, and Mobility in X-linked Hypophosphatemia
Erik A. Imel
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Burosumab in X-linked hypophosphatemia and perspective for chronic kidney disease
Shanthi Balani et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2020)
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
Anthony A. Portale et al.
CALCIFIED TISSUE INTERNATIONAL (2019)
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Timed Up and Go (TUG) Test: Normative Reference Values for Ages 20 to 59 Years and Relationships With Physical and Mental Health Risk Factors
Breelan M. Kear et al.
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2017)
Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease
Jessica Connor et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A Clinician's Guide to X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)